Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

China flag China · Delayed Price · Currency is CNY
6.02
-0.19 (-3.06%)
Apr 25, 2025, 3:04 PM CST
22.86%
Market Cap 7.52B
Revenue (ttm) 1.52B
Net Income (ttm) 412.89M
Shares Out 1.25B
EPS (ttm) 0.33
PE Ratio 18.51
Forward PE 20.07
Dividend 0.12 (1.93%)
Ex-Dividend Date May 29, 2024
Volume 37,019,700
Average Volume 29,924,463
Open 6.15
Previous Close 6.21
Day's Range 5.98 - 6.21
52-Week Range 4.87 - 7.18
Beta 0.14
RSI 55.07
Earnings Date Apr 19, 2025

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers its products in the form of tablets, hard capsules, lyophilized powder and lyophilized powder injections, small-volume injections, and raw materials. It provides enzymes, including pancreatic kininogenase series, asparaginase series, and compound digestive enzyme capsule II; and polysaccharides products, such as nadroparin calcium, enoxaparin sodium, dalteparin sodium, and asparaginase and heparin sodium. The company ... [Read more]

Sector Healthcare
Founded 1971
Employees 1,067
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002550
Full Company Profile

Financial Performance

In 2024, SHE:002550's revenue was 1.53 billion, a decrease of -15.88% compared to the previous year's 1.81 billion. Earnings were 356.03 million, an increase of 95.77%.

Financial Statements

News

There is no news available yet.